Staphylococcus capitis isolated from prosthetic joint infections.
Further knowledge about the clinical and microbiological characteristics of prosthetic joint infections (PJIs) caused by different coagulase-negative staphylococci (CoNS) may facilitate interpretation of microbiological findings and improve treatment algorithms. Staphylococcus capitis is a CoNS with documented potential for both human disease and nosocomial spread. As data on orthopaedic infections are scarce, our aim was to describe the clinical and microbiological characteristics of PJIs caused by S. capitis. This retrospective cohort study included three centres and 21 patients with significant growth of S. capitis during revision surgery for PJI between 2005 and 2014. Clinical data were extracted and further microbiological characterisation of the S. capitis isolates was performed. Multidrug-resistant (≥3 antibiotic groups) S. capitis was detected in 28.6 % of isolates, methicillin resistance in 38.1 % and fluoroquinolone resistance in 14.3 %; no isolates were rifampin-resistant. Heterogeneous glycopeptide-intermediate resistance was detected in 38.1 %. Biofilm-forming ability was common. All episodes were either early post-interventional or chronic, and there were no haematogenous infections. Ten patients experienced monomicrobial infections. Among patients available for evaluation, 86 % of chronic infections and 70 % of early post-interventional infections achieved clinical cure; 90 % of monomicrobial infections remained infection-free. Genetic fingerprinting with repetitive sequence-based polymerase chain reaction (rep-PCR; DiversiLab®) displayed clustering of isolates, suggesting that nosocomial spread might be present. Staphylococcus capitis has the potential to cause PJIs, with infection most likely being contracted during surgery or in the early postoperative period. As S. capitis might be an emerging nosocomial pathogen, surveillance of the prevalence of PJIs caused by S. capitis could be recommended.
Department of Infectious Diseases, Karlstad Hospital, Karlstad, Sweden. staffan.tevell@liv.se.|School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. staffan.tevell@liv.se.
S
S
Tevell
Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
B
B
Hellmark
Department of Infectious Diseases and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Å
Å
Nilsdotter-Augustinsson
School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
B
B
Söderquist
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D018441:Biofilms / Q000254:growth & development; D016000:Cluster Analysis; D024881:Drug Resistance, Bacterial; D005260:Female; D006761:Hospitals; D006801:Humans; D007596:Joints / Q000601:surgery; D008297:Male; D008875:Middle Aged; D017720:Molecular Epidemiology; D058889:Molecular Typing; D010003:Osteoarthritis / Q000453:epidemiology / Q000382:microbiology* / Q000473:pathology / Q000601:surgery; D016459:Prosthesis-Related Infections / Q000453:epidemiology / Q000382:microbiology* / Q000473:pathology / Q000601:surgery; D012189:Retrospective Studies; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000382:microbiology* / Q000473:pathology / Q000601:surgery; D013210:Staphylococcus / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification* / Q000502:physiology; D013548:Sweden / Q000453:epidemiology; D055815:Young Adult
D000900:Anti-Bacterial Agents
Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1169-72
21359622
Int J Infect Dis. 2005 Nov;9(6):335-9
16085441
J Infect Chemother. 2014 Oct;20(10):639-42
25131294
Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):911-7
24338092
Appl Microbiol. 1975 Sep;30(3):381-5
810086
Heart Lung. 2008 Sep-Oct;37(5):380-4
18790338
Heart Lung. 2011 Sep-Oct;40(5):467-71
21411150
Lancet. 1997 Dec 6;350(9092):1670-3
9400512
Int J Artif Organs. 2014 May;37(5):414-21
24968195
J Clin Microbiol. 2008 Sep;46(9):3124-6
18596138
J Clin Microbiol. 2016 Jan;54(1):106-13
26511738
Int J Med Microbiol. 2006 Oct;296(6):381-8
16753338
Anaerobe. 2012 Aug;18(4):392-9
22609518
Perit Dial Int. 2011 May-Jun;31(3):340-6
21454395
APMIS. 2007 Aug;115(8):891-9
17696944
J Clin Microbiol. 2013 Jan;51(1):9-14
23052315
Diagn Microbiol Infect Dis. 2015 Mar;81(3):163-8
25533615
PLoS One. 2012;7(2):e31548
22348102
APMIS. 2015 Jul;123(7):589-95
25951935
Int J Syst Bacteriol. 1991 Jan;41(1):144-7
1995030
J Antimicrob Chemother. 2014 Sep;69 Suppl 1:i21-4
25135084
J Clin Microbiol. 2002 Jul;40(7):2520-5
12089273
Pediatr Rep. 2010 Jun 18;2(1):e2
21589838
Eur J Clin Microbiol Infect Dis. 2009 Jun;28(6):655-60
19034541
Clin Infect Dis. 2013 Jan;56(1):e1-e25
23223583
Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1349-54
21744039
ANZ J Surg. 2011 Jan;81(1-2):32-9
21299796
FEMS Immunol Med Microbiol. 2012 Jul;65(2):158-68
22309166
Diagn Microbiol Infect Dis. 2013 Mar;75(3):235-9
23313084
Int J Artif Organs. 2010 Sep;33(9):568-74
20963723
J Clin Microbiol. 1995 Apr;33(4):816-20
7790443
J Clin Microbiol. 2005 Jun;43(6):2952-4
15956429